Evaluation of lipoprotein‐associated phospholipase A2 as a marker for renal microvasculopathy in adolescents with Type 1 diabetes-Reference-Cited by-同舟云学术

Evaluation of lipoprotein‐associated phospholipase A2 as a marker for renal microvasculopathy in adolescents with Type 1 diabetes

Published:2019-08-05 Issue:1 Volume:37 Page:75-83
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Seyfarth J.¹^ORCID,Herebian D.¹,Reinauer C.¹,Baechle C.²³,Roden M.³⁴⁵,Holl R. W.³⁶,Reinehr T.⁷,Mayatepek E.¹,Meissner T.¹³,Rosenbauer J.²³^ORCID

Affiliation:

1. Department of General Pediatrics, Neonatology and Pediatric Cardiology University Children's Hospital, Medical Faculty Duesseldorf Germany

2. Institute for Biometrics and Epidemiology German Diabetes Center Leibniz Center at Heinrich‐Heine University Duesseldorf Duesseldorf Germany

3. German Center for Diabetes Research (DZD)Munich‐Neuherberg Germany

4. Division of Endocrinology and Diabetology Medical Faculty, Heinrich Heine University Duesseldorf Duesseldorf Germany

5. Institute for Clinical Diabetology German Diabetes Center Leibniz Center at Heinrich Heine University Duesseldorf Duesseldorf Germany

6. Institute of Epidemiology and Medical Biometry ZIBMT, University of Ulm Ulm Germany

7. Department of Pediatric Endocrinology, Diabetes and Nutrition Medicine Vestische Hospital for Children and Adolescents Datteln University of Witten/Herdecke Datteln Germany

Funder

Bundesministerium für Bildung und Forschung

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14086

Reference30 articles.

1. Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

2. Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target

3. Lp-PLA2 activity is associated with increased risk of diabetic retinopathy: a longitudinal disease progression study

4. Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes

5. Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The predictive value of miR-377 and phospholipase A2 in the early diagnosis of diabetic kidney disease and their relationship with inflammatory factors;Immunobiology;2024-03

2. Diabetic kidney disease in children and adolescents: an update;Pediatric Nephrology;2021-12-16

3. Correlation between Serum LP-PLA2 and sST2 Levels and the Condition of Patients with Acute Heart Failure and Their Prognostic Value;Evidence-Based Complementary and Alternative Medicine;2021-10-18

4. EXPRESSIONS AND DIAGNOSTIC VALUE OF SERUM PENTRAXIN 3, SMALL AND DENSE LOW-DENSITY LIPOPROTEIN AND LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CAROTID ATHEROSCLEROSIS PATIENTS;ACTA MEDICA MEDITERR;2021